Product
AS03
4 clinical trials
5 indications
Indication
Avian InfluenzaIndication
Influenza ImmunizationIndication
Influenza A virus subtype H1N1Indication
InfluenzaIndication
COVID-19Clinical trial
A Phase II Study in Healthy Adults 19 Years and Older to Assess the Safety, Reactogenicity and Immunogenicity of a Sanofi Pasteur A/H7N9 Inactivated Influenza Vaccine Administered Intramuscularly With or Without AS03 AdjuvantStatus: Completed, Estimated PCD: 2019-09-26
Clinical trial
A Phase II Study to Evaluate and Compare the Immunogenicity of Monovalent Inactivated Influenza A/H7N9 Virus Vaccine Administered With and Without AS03 Adjuvant and Monovalent Inactivated Influenza A/H3N2v Virus Vaccine Administered Without Adjuvant in Healthy Adults Through Standard and Systems Biology AnalysesStatus: Completed, Estimated PCD: 2017-03-28
Clinical trial
Phase 2 Clinical Trial to Optimize Immune Coverage of SARS-CoV-2 Existing and Emerging VariantsStatus: Completed, Estimated PCD: 2023-11-22
Clinical trial
A Phase I Cohort-Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants: Assessment of Immunological Responses and Lymphocyte InterplayStatus: Completed, Estimated PCD: 2018-12-19